Colchicine
Back to searchMolecule Structure
Scientific Name
Colchicine
Description of the Drug
Colchicine is an alkaloid used in the symptomatic relief of pain in attacks of gout and to treat the inflammatory symptoms of Familial Mediterranean Fever (FMF).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01394
http://www.drugbank.ca/drugs/DB01394
Brand Name(s)
Colchicine, Colcrys, Gloperba, Mitigare
Company Owner(s)
Alkem Laboratories Ltd, Takeda Pharmaceuticals Usa Inc, Watson Laboratories Inc, Merck And Co Inc, Granules Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Lederle Laboratories Div American Cyanamid Co, Novast Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095182 |
Clinical Trial(s)
Unichem Links
| Atlas | colchicine | ||||
| SureChEMBL | SCHEMBL8469 | ||||
| PharmGKB | PA449092 | ||||
| DrugBank | DB01394 | ||||
| PubChem: Thomson Pharma | 14756995 | ||||
| PubChem | 6167 | ||||
| Mcule | MCULE-7858118731 | MCULE-1568647156 | |||
| NMRShiftDB | 60000009 | ||||
| LINCS | LSM-5199 | ||||
| Nikkaji | J9.267C | ||||
| PDBe | LOC | ||||
| BindingDB | 50014846 | ||||
| EPA CompTox Dashboard | DTXSID5024845 | ||||
| DrugCentral | 726 | ||||
| Metabolights | MTBLC27882 | ||||
| Brenda | 8394 | 229303 | 48923 | 229302 | 3334 |
| ChemicalBook | CB6391144 | ||||
| Guide to Pharmacology | 2367 | ||||
| rxnorm | MITIGARE | GLOPERBA | COLCRYS | COLCHICINE | |
| PubChem: Drugs of the Future | 12012587 | ||||
| KEGG Ligand | C07592 | ||||
| ChEBI | 27882 | ||||
| ZINC | ZINC000000621853 |
